Mutation of the Conserved Threonine 8 within the Human ARF Tumour Suppressor Protein Regulates Autophagy.
INK4a/ARF locus
LC3
autophagy
cancer
cytoskeleton
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
13 01 2022
13 01 2022
Historique:
received:
13
11
2021
revised:
06
01
2022
accepted:
10
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
1
4
2022
Statut:
epublish
Résumé
The ARF tumour suppressor plays a well-established role as a tumour suppressor, halting cell growth by both p53-dependent and independent pathways in several cellular stress response circuits. However, data collected in recent years challenged the traditional role of this protein as a tumour suppressor. Cancer cells expressing high ARF levels showed that its expression, far from being dispensable, is required to guarantee tumour cell survival. In particular, ARF can promote autophagy, a self-digestion pathway that helps cells cope with stressful growth conditions arising during both physiological and pathological processes. We previously showed that ARF is regulated through the activation of the protein kinase C (PKC)-dependent pathway and that an ARF phospho-mimetic mutant on the threonine residue 8, ARF-T8D, sustains cell proliferation in HeLa cells. We now explored the role of ARF phosphorylation in both basal and starvation-induced autophagy by analysing autophagic flux in cells transfected with either WT and ARF phosphorylation mutants by immunoblot and immunofluorescence. Here, we show that endogenous ARF expression in HeLa cells is required for starvation-induced autophagy. Further, we provide evidence that the hyper-expression of ARF-T8D appears to inhibit autophagy in both HeLa and lung cancer cells H1299. This effect is due to the cells' inability to elicit autophagosomes formation upon T8D expression. Our results lead to the hypothesis that ARF phosphorylation could be a mechanism through which the protein promotes or counteracts autophagy. Several observations underline how autophagy could serve a dual role in cancer progression, either protecting healthy cells from damage or aiding cancerous cells to survive. Our results indicate that ARF phosphorylation controls protein's ability to promote or counteract autophagy, providing evidence of the dual role played by ARF in cancer progression.
Sections du résumé
BACKGROUND
The ARF tumour suppressor plays a well-established role as a tumour suppressor, halting cell growth by both p53-dependent and independent pathways in several cellular stress response circuits. However, data collected in recent years challenged the traditional role of this protein as a tumour suppressor. Cancer cells expressing high ARF levels showed that its expression, far from being dispensable, is required to guarantee tumour cell survival. In particular, ARF can promote autophagy, a self-digestion pathway that helps cells cope with stressful growth conditions arising during both physiological and pathological processes.
METHODS
We previously showed that ARF is regulated through the activation of the protein kinase C (PKC)-dependent pathway and that an ARF phospho-mimetic mutant on the threonine residue 8, ARF-T8D, sustains cell proliferation in HeLa cells. We now explored the role of ARF phosphorylation in both basal and starvation-induced autophagy by analysing autophagic flux in cells transfected with either WT and ARF phosphorylation mutants by immunoblot and immunofluorescence.
RESULTS
Here, we show that endogenous ARF expression in HeLa cells is required for starvation-induced autophagy. Further, we provide evidence that the hyper-expression of ARF-T8D appears to inhibit autophagy in both HeLa and lung cancer cells H1299. This effect is due to the cells' inability to elicit autophagosomes formation upon T8D expression.
CONCLUSIONS
Our results lead to the hypothesis that ARF phosphorylation could be a mechanism through which the protein promotes or counteracts autophagy. Several observations underline how autophagy could serve a dual role in cancer progression, either protecting healthy cells from damage or aiding cancerous cells to survive. Our results indicate that ARF phosphorylation controls protein's ability to promote or counteract autophagy, providing evidence of the dual role played by ARF in cancer progression.
Identifiants
pubmed: 35053274
pii: biom12010126
doi: 10.3390/biom12010126
pmc: PMC8773949
pii:
doi:
Substances chimiques
TP53 protein, human
0
Tumor Suppressor Protein p14ARF
0
Tumor Suppressor Protein p53
0
Tumor Suppressor Proteins
0
Threonine
2ZD004190S
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Biol Chem. 2009 Jan 30;284(5):2803-2810
pubmed: 19049976
Mol Cell. 2006 May 19;22(4):463-75
pubmed: 16713577
Mol Cell. 2003 Feb;11(2):415-24
pubmed: 12620229
J Cell Physiol. 2011 Aug;226(8):2189-97
pubmed: 21520071
Br J Cancer. 2006 Dec 18;95(12):1670-7
pubmed: 17117177
Mol Cell Biol. 2000 Apr;20(7):2517-28
pubmed: 10713175
Biomolecules. 2021 Jul 30;11(8):
pubmed: 34439790
Mutat Res. 2005 Aug 25;576(1-2):22-38
pubmed: 15878778
Cancer Res. 2008 Dec 1;68(23):9608-13
pubmed: 19047137
Oncogene. 2017 Aug 24;36(34):4913-4928
pubmed: 28436949
Autophagy. 2013 Oct;9(10):1553-65
pubmed: 23939042
PLoS One. 2013;8(1):e53631
pubmed: 23308265
Cancers (Basel). 2018 Jun 29;10(7):
pubmed: 29966311
Mol Cell. 2006 May 19;22(4):436-7
pubmed: 16713573
Sci Rep. 2018 May 4;8(1):7056
pubmed: 29728595
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15930-5
pubmed: 14665695
Int J Cancer. 2010 Nov 15;127(10):2239-47
pubmed: 20549699
Cancer Res. 2008 Jan 15;68(2):352-7
pubmed: 18199527
Biomolecules. 2019 Mar 04;9(3):
pubmed: 30836703
Sci Signal. 2009 Aug 18;2(84):ra44
pubmed: 19690330
PLoS One. 2015 Feb 27;10(2):e0117252
pubmed: 25723571
Front Genet. 2014 Jul 22;5:236
pubmed: 25101116
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7689-94
pubmed: 15897463
Cancer Res. 2017 Feb 15;77(4):1035-1046
pubmed: 28082400
Pharmaceuticals (Basel). 2019 May 15;12(2):
pubmed: 31096606
Curr Opin Genet Dev. 2000 Feb;10(1):94-9
pubmed: 10679383